Drug Screening Using Novel IMD in Renal Cell Carcinoma

Clinical trial NCT05700461 · RECRUITING

Trial details

NCT number: NCT05700461
Sponsor: Oliver Jonas
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Metastatic Renal Cell Carcinoma Kidney Cancer

Start date: 2024-12-01
Primary completion: 2028-10-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.